Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor B (SIII), polypeptide 1 pseudogene 2 (ELOCP2)
- Target
- ELOCP2
- Molecular classification
- Pseudogene
01
Overview
ELOCP2 (elongin C pseudogene 2) is a **pseudogene** related to the elongin C gene, which encodes a regulatory subunit of the general transcription elongation factor complex known as SIII. Unlike its protein-coding counterpart, the ELOCP2 locus does not produce a functional protein and has no established role as a receptor, enzyme, or therapeutic target. Pseudogenes can sometimes exert regulatory effects or be transcriptionally active, but ELOCP2 currently has no known biological function or clinical relevance as a drug target[3][10][11].
- Other names
- Transcription elongation factor B (SIII), subunit 1 pseudogene 2TCEB1P2 (alternative pseudogene-style symbol; not widely used)
02
Mechanism of action
None (not a drug target)
03
Biological functions
None (no known protein product or established biological function; as a pseudogene, it may have regulatory non-coding functions, but none are reported for ELOCP2)
04
Disease associations
None established (no direct disease association; pseudogenes can be involved in regulation or disease in rare cases, but there is no evidence for ELOCP2)
05
Safety considerations
None (as it is not a therapeutic target)
06
Interacting drugs
None (no encoded protein, so no direct drug interactions)
07
Biomarkers
None reported
Beyond the preview
Go deeper on Transcription elongation factor B (SIII), polypeptide 1 pseudogene 2 (ELOCP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transcription elongation factor B (SIII), polypeptide 1 pseudogene 2 (ELOCP2).